Vaccine in order
| Vaccine | Approval | Deployment |
|---|---|---|
| Sinopharm BIBP |  Yes | 23 February 2021 |
| Oxford–AstraZeneca | Yes | Yes |
| Date | 23 February 2021 - present |
|---|---|
| Location | Senegal |
| Cause | COVID-19 pandemic |
On 23 February 2021, Senegal began its national vaccination program against the COVID-19. [1] As of 10 March, 68,205 people in Senegal have been able to be vaccinated. [2] [3]
On 23 February 2021, [4] Senegal began its national vaccination program against COVID-19 using the Sinopharm BIBP vaccine. [5]
By the end of the month 309,128 vaccine doses had been administered, including 260,754 first doses.
By the end of the month 470,009 vaccine doses had been administered, including 406,981 first doses.
By the end of the month more than half a million vaccine doses had been administered, including 456,135 first doses.
By the end of the month 0.7 million vaccine doses had been administered, including 0.5 million first doses.
By the end of the month 1.1 million vaccine doses had been administered while 806,510 persons had been vaccinated. [6]
By the end of the month 1.6 million vaccine doses had been administered while 1,167,364 persons had been vaccinated. [7]
By the end of the month 1.8 million vaccine doses had been administered while 1,251,403 persons had been vaccinated. [8]
By the end of the month 1.9 million vaccine doses had been administered, including 1.3 million first doses, and 13% of the targeted population had been fully vaccinated.
By the end of the month 1.9 million vaccine doses had been administered, including 1.3 million first doses, and 13% of the targeted population had been fully vaccinated.
By the end of the month two million vaccine doses had been administered, including 1.4 million first doses, and 14% of the targeted population had been fully vaccinated.
By the end of the month two million vaccine doses had been administered, including 1.4 million first doses, and 14% of the targeted population had been fully vaccinated.
By the end of the month 2.5 million vaccine doses had been administered, including 1.5 million first doses, while more than a million persons had been fully vaccinated.
By the end of the month 2.5 million vaccine doses had been administered, including 1.5 million first doses, while more than a million persons had been fully vaccinated.
By the end of the month 2.5 million vaccine doses had been administered, including 1.5 million first doses, while more than a million persons had been fully vaccinated.
| Vaccine | Approval | Deployment |
|---|---|---|
| Sinopharm BIBP | Yes | 23 February 2021 |
| Oxford–AstraZeneca | Yes | Yes |
Cumulative vaccinations [3] The following figure presents the cumulative number of people in Senegal who have been vaccinated (vertical axis) since the starting date of vaccinations in Senegal (horizontal axis: date)
 | Graphs are unavailable due to technical issues. There is more info on Phabricator and on MediaWiki.org. |
The COVID-19 pandemic in Senegal was a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Senegal on March 2, 2020.
The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine, not to be confused with the similar product name of CoronaVac.
On 22 February 2021, Zimbabwe launched their national COVID-19 vaccination program using the Sinopharm BIBP vaccine. As of 17 June 2022, 6,260,228 people have received their first dose, 4,598,703 have received their second dose, and 851,874 have received a third dose.
On 29 January 2021, Algeria launched a COVID-19 vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.
The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 15 June 2021, Angola has administered 1,314,375 doses of vaccines.822,109 people with the first dose and 492,266 people fully vaccinated. Angola began their vaccination program shortly after receiving their first shipment of Oxford AstraZeneca vaccine in early March 2021.
COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
Burkina Faso started vaccinating against COVID-19 on 2 June 2021.
Cape Verde has begun vaccinations against COVID-19.
COVID-19 vaccination programs are ongoing in the majority countries and territories in Africa, with 51 of 54 African countries having launched vaccination programs by July 2021. As of October 2023, 51.8% of the continent's population is fully vaccinated with over 1084.5 million doses administered.
COVID-19 vaccination in Ghana began on Monday 1 March 2021 after the country became the first recipient of the Oxford-AstraZeneca COVID-19 vaccine as part of the COVAX initiative. As of 6 June 2021, Ghana has administered 1,230,000 vaccine doses.
COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 28 February 2022, 17,914,944 people have received their first dose a COVID-19 vaccine, and 8,197,832 have received their second dose.
COVID-19 vaccination in Burundi is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Burundi was one of the last nation states in the world to commence vaccination against COVID-19. This was mostly due to the government's refusal to vaccinate the population throughout most of 2021. In February 2021, Thaddee Ndikumana, the health minister of Burundi, said his country was more concerned with prevention measures. "Since more than 95% of patients are recovering, we estimate that the vaccines are not yet necessary," local media reported.
COVID-19 vaccination in Cameroon is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Chad is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Djibouti is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Equatorial Guinea is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Eswatini is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in the Democratic Republic of the Congo is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
 | This article about COVID-19 vaccines is a stub. You can help Wikipedia by expanding it. |
 | This Senegal-related article is a stub. You can help Wikipedia by expanding it. |